Ziopharm Oncology (ZIOP) Reports In-Line Q1 EPS

May 6, 2021 6:18 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Ziopharm Oncology (NASDAQ: ZIOP) reported Q1 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Cash and cash equivalents, as of March 31, 2021 were $100.1 million.

For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities